myLaurel® | $12,000,000 | (Jun 4, 2025)
Matterworks | Undisclosed Amount | (Jun 4, 2025)
Ciroos | $21,000,000 | (Jun 4, 2025)
Certified by Founder
Lodge
GC Therapeutics
start up
United States
- Cambridge, MA
- 24/09/2024
- Series A
- $65,000,000
GC Therapeutics Inc. (GCTx) uses synthetic biology to program patient-derived stem cells into any cell type with best-in-class efficiency (up to 10X), speed (up to 100X) and scalability. We dictate cells fates in a single step and have validated cells for many applications. We have also developed SuperCells™ by tailoring cells for specific diseases.
The core technology of GCTx was conceived, invented and perfected in Professor George Church’s lab at Harvard Medical School. We are a group of passionate biologists and tissue engineers whose goal is to bring this breakthrough approach to patients.
- Industry Biotechnology Research
- Website https://www.gc-tx.com/
- LinkedIn https://www.linkedin.com/company/gctx/
FISPAN | $30,000,000 | (Jun 4, 2025)
Volare Solutions | $29,578,562 | (Jun 4, 2025)
Veris AI | $8,500,000 | (Jun 4, 2025)
Clara(US) | $3,100,000 | (Jun 4, 2025)
ProteinQure | $11,000,000 | (Jun 4, 2025)
Dexari | $2,300,000 | (Jun 3, 2025)
Heron Power | $38,000,000 | (Jun 3, 2025)
Trustifi | $25,000,000 | (Jun 3, 2025)
Literal Labs | $6,223,938 | (Jun 3, 2025)